JP2014512403A5 - - Google Patents

Download PDF

Info

Publication number
JP2014512403A5
JP2014512403A5 JP2014506862A JP2014506862A JP2014512403A5 JP 2014512403 A5 JP2014512403 A5 JP 2014512403A5 JP 2014506862 A JP2014506862 A JP 2014506862A JP 2014506862 A JP2014506862 A JP 2014506862A JP 2014512403 A5 JP2014512403 A5 JP 2014512403A5
Authority
JP
Japan
Prior art keywords
composition
collagen
weight
total weight
monosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014512403A (ja
JP6050320B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/057647 external-priority patent/WO2012146655A1/en
Publication of JP2014512403A publication Critical patent/JP2014512403A/ja
Publication of JP2014512403A5 publication Critical patent/JP2014512403A5/ja
Application granted granted Critical
Publication of JP6050320B2 publication Critical patent/JP6050320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506862A 2011-04-27 2012-04-26 止血組成物 Active JP6050320B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161517973P 2011-04-27 2011-04-27
US61/517,973 2011-04-27
EP11305492.8 2011-04-27
EP11305492 2011-04-27
PCT/EP2012/057647 WO2012146655A1 (en) 2011-04-27 2012-04-26 Hemostatic compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016228298A Division JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Publications (3)

Publication Number Publication Date
JP2014512403A JP2014512403A (ja) 2014-05-22
JP2014512403A5 true JP2014512403A5 (enExample) 2015-06-18
JP6050320B2 JP6050320B2 (ja) 2016-12-21

Family

ID=46022222

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014506862A Active JP6050320B2 (ja) 2011-04-27 2012-04-26 止血組成物
JP2016228298A Active JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016228298A Active JP6235104B2 (ja) 2011-04-27 2016-11-24 止血組成物

Country Status (15)

Country Link
US (6) US9283187B2 (enExample)
EP (3) EP3922261A1 (enExample)
JP (2) JP6050320B2 (enExample)
CN (2) CN106390186B (enExample)
AU (4) AU2012247480B2 (enExample)
BR (2) BR122021017027B1 (enExample)
CA (2) CA3108894A1 (enExample)
CY (1) CY1122251T1 (enExample)
DK (1) DK3513803T3 (enExample)
ES (1) ES2882911T3 (enExample)
PL (2) PL2701729T3 (enExample)
RS (1) RS59243B1 (enExample)
SI (1) SI2701729T1 (enExample)
SM (1) SMT201900467T1 (enExample)
WO (1) WO2012146655A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
WO2012146655A1 (en) * 2011-04-27 2012-11-01 Biom'up Hemostatic compositions
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2825216B1 (en) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
RU2678592C1 (ru) * 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Сухая композиция, содержащая компонент, улучшающий экструзию
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
WO2016112026A1 (en) * 2015-01-06 2016-07-14 St. Teresa Medical, Inc. Hemostatic products
WO2016118043A1 (ru) * 2015-01-20 2016-07-28 Виктор Вениаминович ТЕЦ Гемостатическое средство
RU2717356C2 (ru) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Шприц для удерживания вакуума в состоянии хранения
CA3004734A1 (en) 2015-11-12 2017-06-18 St. Teresa Medical, Inc. A method of sealing a durotomy
PL3496770T3 (pl) 2016-08-12 2021-09-27 Biom'up France SAS Hemostatyczny płynny materiał
EP3630082A4 (en) 2017-05-24 2021-12-15 Viktor Veniaminovich Tets FRACTIONED ANTIMICROBIAL COMPOSITIONS AND THEIR USE
WO2019089717A1 (en) 2017-11-02 2019-05-09 St. Teresa Medical, Inc. Fibrin sealant products
IL276693B2 (en) * 2018-02-15 2023-11-01 Biomup France Sas Multi-dimensional hemostatic product and method for producing the same
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법
CN109674496B (zh) * 2018-08-01 2019-11-15 浙江三创生物科技有限公司 输送药剂的器件及其装置和组件
KR102093839B1 (ko) * 2019-05-28 2020-05-04 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US11027041B2 (en) * 2019-06-30 2021-06-08 James Drake Stable and robust blended hemostatic composition
JP7550390B2 (ja) 2020-05-08 2024-09-13 国立大学法人 東京大学 止血用ポリマー材料キット
KR102521769B1 (ko) * 2020-07-20 2023-04-14 주식회사 테라시온바이오메디칼 국소 지혈 파우더 조성물 및 이의 제조방법
EP4580751A2 (en) 2022-09-29 2025-07-09 Adora Animal Health Corporation Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3175003D1 (en) 1981-06-25 1986-08-28 Serapharm Gmbh & Co Kg Enriched plasma derivative for promoting wound sealing and wound healing
US4515637A (en) 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4942153A (en) 1987-02-03 1990-07-17 Fernandez Helen M Skin moisturizing product and process
US5263984A (en) * 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
IT1263394B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
DE19520575A1 (de) 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
US6096309A (en) 1997-06-18 2000-08-01 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar nanometer collagen, and methods for preparation and use thereof
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
CN1198603C (zh) 1998-08-20 2005-04-27 3M创新有限公司 形成绷带和药物输递系统的喷雾液体
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
AT411326B (de) 2000-06-20 2003-12-29 Biering Wolfgang Hämostatische collagen-pellets
AT412445B (de) * 2000-06-20 2005-03-25 Biering Wolfgang Flüssiges collagen-hämostatikum
US20030003157A1 (en) * 2001-06-06 2003-01-02 University Of Medicine & Dentistry Of New Jersey Collagen compositions and methods for making and using the same
US6613348B1 (en) * 2001-07-31 2003-09-02 Manoj K. Jain Process of controlling absorbency in collagen flakes
JP3805654B2 (ja) 2001-08-29 2006-08-02 株式会社ネクスト 止血・癒着防止性のバイオポリマーの微細粒子
WO2003026709A1 (en) 2001-09-26 2003-04-03 Mbs Multination Business Services (G.B.) Ltd. Liquid mixture for use as a dressing spray
EP1501558A1 (de) 2002-05-08 2005-02-02 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Resorbierbare pharmazeutische formulierung zur kontinuierlichen thrombinfreisetzung
AUPS242702A0 (en) * 2002-05-21 2002-06-13 Colltech Australia Limited Improved method for the extraction and purification of collagen
US8153591B2 (en) * 2003-08-26 2012-04-10 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
CN1554448A (zh) 2003-12-23 2004-12-15 张淑荣 壳聚糖明胶聚乙烯醇生物止血敷料
WO2005072700A2 (en) * 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
KR101186081B1 (ko) * 2004-03-17 2012-09-26 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 기능성 분체
EP1580229A1 (en) 2004-03-22 2005-09-28 Warner-Lambert Company Llc Biopolymer compositons and products thereof
WO2005115252A1 (ja) 2004-05-13 2005-12-08 Nakanishi Inc. 経内視鏡手術に用いる止血と、癒着の防止装置
JP4959557B2 (ja) * 2004-07-09 2012-06-27 フェロサン メディカル デバイシーズ エイ/エス ヒアルロン酸含有止血合成剤
MY142987A (en) 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
CN1709507A (zh) 2005-06-29 2005-12-21 肖春 外用复方止血镇痛消炎药
CN101272790A (zh) * 2005-09-22 2008-09-24 特罗比奥股份公司 稳定的蛋白酶组合物
JP5040234B2 (ja) 2006-09-26 2012-10-03 三菱電機株式会社 圧接型半導体装置
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
EP2219572A4 (en) 2007-12-06 2014-05-28 Nanosys Inc RESORBABLE HEMOSTATIC STRUCTURES ENHANCED BY NANOMATERIAL AND BANDING MATERIALS
KR101541702B1 (ko) * 2008-03-03 2015-08-04 옴릭스 바이오파머슈티컬스 리미티드 활성 성분을 포함하는 젤라틴 스펀지, 이의 제조 방법 및 용도
FR2944706B1 (fr) 2009-04-28 2012-08-24 Biom Up Nouveaux materiaux en collagene et procedes d'obtention.
CN101757614B (zh) * 2010-02-22 2012-04-04 苏州汇涵医用科技发展有限公司 止血剂及其制备方法
CN101837143A (zh) * 2010-04-22 2010-09-22 胡堃 一种药物缓释止血组合物及制备方法
WO2012146655A1 (en) * 2011-04-27 2012-11-01 Biom'up Hemostatic compositions

Similar Documents

Publication Publication Date Title
JP2014512403A5 (enExample)
Li et al. Nanocellulose/gelatin composite cryogels for controlled drug release
WO2011159866A3 (en) Bone filler material
JP2011513034A5 (enExample)
JP2011046962A5 (enExample)
JP2016094516A5 (enExample)
IN2012DN03632A (enExample)
JP2014223087A5 (enExample)
JP2016527890A5 (enExample)
WO2013127598A3 (de) Verwendung von pulvercellulose in kosmetika
NZ603411A (en) Pazopanib compositions and their use in treating ocular diseases
JP2016505044A5 (enExample)
RU2015132974A (ru) Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу
RU2016131243A (ru) Курительное изделие с материалом доставки жидкости
JP2016163597A5 (enExample)
BR112012013503A2 (pt) suspensões de nanopartícula contendo polímero de carboxivinila
BR112015007045A2 (pt) composição de cuidado pessoal
WO2010122258A3 (fr) Procede de fabrication de particules de poudre libre a base de polyamide impregnee d'au moins un agent cosmetique ou pharmaceutique, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique
JP2014076971A5 (enExample)
JP2010517546A5 (enExample)
JP2017066046A5 (enExample)
JP2014513936A5 (enExample)
JP2018505805A5 (enExample)
JP2009161439A5 (enExample)
RU2018144958A (ru) Композиции, содержащие полисахаридную матрицу для контролируемого высвобождения активных ингредиентов